Resmed Inc. buy UBS Group AG
Start price
20.09.25
/
50%
€234.30
Target price
20.09.26
-
Performance (%)
-9.73%
Price
11:42
€211.50
Summary
This prediction is currently active. With a performance of -9.73%, the BUY prediction by UBS_Group_AG is trending in the wrong direction. This prediction currently runs until 20.09.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | -1.019% | -1.019% |
| iShares Core DAX® | 0.024% | 0.583% |
| iShares Nasdaq 100 | 1.740% | -2.061% |
| iShares Nikkei 225® | 0.428% | 10.487% |
| iShares S&P 500 | 1.329% | 0.140% |
Comments by UBS_Group_AG for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Ratings data for RMD provided by MarketBeat